+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical Chemistry Analyzers Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis

  • PDF Icon

    Report

  • 205 Pages
  • October 2023
  • Region: Global
  • Renub Research
  • ID: 5895554
Clinical Chemistry Analyzer Market size is expected to attain US$ 19.02 Billion by 2030, according to the report. Clinical chemistry refers to the biochemical analysis of the frame fluids, in which extraordinary chemical reactions are observed to determine the volume of diverse chemicals. Clinical chemistry, a clinical pathology department, assesses frame fluids for disease prognosis and treatment. It's used in metabolic feature tests, like diabetes and drug-of-abuse screening. Clinical analyzer's automated devices employ ion-selective potentiometry, latex agglutination, and photometric/colorimetric testing to examine blood serum, plasma, and urine.

Worldwide available analyzers include:

  • Benchtop fashions
  • Compact bedside devices (with fewer tests)
  • High-throughput floor-primarily based machines
The worldwide clinical chemistry analyzer market flourishes due to technological advancements, accelerated health awareness, and efforts by healthcare industries to improve facts and reliability. Yet, demanding situations include high costs, a scarcity of educated professionals, and uncertainty risks.

An extensive driving force in the market is the rising incidence of chronic diseases like diabetes. The ongoing surge in disease occurrence has compelled companies to mass-produce advanced analyzers for progressive diagnostic capabilities. Consequently, intense competition has emerged because of the demand for chemical analyzers and the substantial inflow of the latest market providers. Technological improvements in clinical chemistry analyzers have enabled broader testing skills and early sickness detection, particularly in specialized sectors like cancer, gynecology, and endocrinology. Notable improvements consist of enhanced resolution, refined pattern reputation, computer-assisted interpretation, advanced modeling, parameter estimation, and the integration of artificial intelligence.

According to the WHO, through 2030, about 1 in 6 human beings may be elderly (60 or older), with the worldwide elderly population expected to reach 1.4 billion in 2030 (up from 1 billion in 2020) and expected to achieve 2.1 billion with the aid of 2050. The GLOBOCAN 2020 record states that the global cancer instances in 2020 were about 19.3 million, projected to grow to 28.9 million with the assistance of 2040. The IDF Diabetes Atlas, Tenth Edition 2021, reports 537 million adults with diabetes in 2021, expected to attain 643 million by 2030 and 783 million by 2045 globally.

Clinical chemistry analyzer market is anticipated to develop at a CAGR of 4.35% during the forecast duration (2023-2030)

The clinical chemistry and immunochemistry analyzers allow immunoassay-primarily-based testing, which greatly increases the spectrum of assessments that can be performed on a single device and reduces the time required for high-quality checks and protection of those analyzers. The automatic and integrated analyzers come in one-of-a-kind sample workloads and volumes (low, medium, and excessive) to shape the necessities of the health facility and reference labs, similarly contributing to growing demand and market increase. Thus, the increasingly aged populace is vulnerable to numerous persistent illnesses, resulting in an excessive need for medical tests. The clinical chemistry analyzer industry is expected to grow over the forecast period. The clinical chemistry analyzer market is worth US$ 14.12 Billion in 2023.

Reagents market is about to preserve its growth, which is crucial for advancing clinical diagnostics

By Product Type, The global clinical chemistry analyzer market is segmented into analyzers, reagents, and others. The global clinical chemistry analyzer market witnesses the reagents market reigning supreme as it claims the top position. This dominance is driven by reagents' pivotal role in facilitating accurate diagnostic tests and clinical research. These essential chemical substances enable clinical chemistry analyzers to detect and measure various biomarkers, making them indispensable in the healthcare industry. As the demand for advanced medical diagnostics continues to surge worldwide, the reagents market remains at the forefront, ensuring the reliable functioning of clinical chemistry analyzers and contributing significantly to advancements in medical science and patient care.

Basic Metabolic Panel (BMP) holds the biggest market within the clinical chemistry analyzer industry

By Test Type, the global clinical chemistry analyzer market is divided into Basic Metabolic Panels, Liver Panels, Renal Profiles, Lipid Profiles, Thyroid Function Panels, Electrolyte Panels, and Specialty Chemical Assessments. The Basic Metabolic Panel (BMP) commands the largest market share in the clinical chemistry analyzer industry. This comprehensive diagnostic tool is crucial in assessing a patient's health by measuring key metabolic markers such as glucose, calcium, and electrolytes. Its widespread adoption stems from its ability to provide essential insights into various physiological functions, aiding in the early detection and management of metabolic disorders and chronic conditions. As healthcare systems worldwide prioritize preventive care and early intervention, the BMP's prominence is set to continue, making it a cornerstone in the medical chemistry analyzer landscape and improving patient outcomes.

Hospitals have emerged as the dominant clinical chemistry analysis industry players, securing the best market share

By End User, the global clinical chemistry analyzer market is segmented into Hospitals, Research Laboratories & Institutes, Diagnostic Laboratories, and Others. Hospitals have become prominent in the clinical chemistry analyzers industry, securing most market revenues. This shift underscores the pivotal role that healthcare institutions play in patient diagnosis, treatment, and monitoring. Clinical chemistry analyzers, renowned for their capability to deliver precise measurements of diverse biomarkers, have become essential instruments in hospital laboratories. They empower healthcare providers to make informed decisions regarding patient care, enhancing the accuracy of diagnoses and treatment strategies. As the demand for advanced medical diagnostics and comprehensive patient care continues to expand, hospitals continue to lead in innovation and maintain their position as top market performers in this crucial sector.

United States boasts a thriving clinical chemistry analyzer industry characterized by innovation, advanced generation, and great market presence

By country, the Global Clinical Chemistry Analyzers Market is segmented into the United States, Canada, Germany, United Kingdom, France, Italy, Netherlands, Spain, China, South Korea, Japan, India, Indonesia, Malaysia, Argentina, Brazil, Mexico, Colombia, Saudi Arabia, South Africa, Israel, Australia, UAE, and Rest of World. The United States is home to a vibrant clinical chemistry analyzer industry, characterized by its proud tradition of cutting-edge innovation and a robust research and development framework. This nation takes the lead in the global market for manufacturing advanced diagnostic equipment, enjoying a reputation for excellence in healthcare. The industry's success is underpinned by a strong dedication to delivering superior healthcare solutions and responding to the growing demand for precise diagnostics. U.S.-based manufacturers continually introduce state-of-the-art clinical chemistry analyzers that cater to the evolving requirements of healthcare providers. This thriving sector significantly benefits domestic healthcare and extends its global influence by exporting products, establishing the United States as a dominant force in advancing healthcare worldwide through clinical chemistry analyzers.

Key Player

Some clinical chemistry analyzer market players are Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Danaher Corporation, Johnson & Johnson, Sysmex ADR, HORIBA Ltd., and Hitachi.

The “Clinical Chemistry Analyzer Market Global Forecast by Product Type (Analyzers, Reagents and Others), By Test Type (Basic Metabolic Panel, Electrolyte Panel, Liver Panel, Liver Profile, Renal Profile, Thyroid Functional Panel and Specialty Chemical Tests), By End Users (Hospitals, Academic Research Centers, Diagnostic Laboratories and Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Key Players Analysis (Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Danaher Corporation, Johnson & Johnson, Sysmex ADR, HORIBA, Ltd and Hitachi)" provides a detailed analysis of Global Clinical Chemistry Industry.

Product Type

1. Analyzers
2. Reagents
3. Others

Test Type

1. Basic Metabolic Panel
2. Liver Panel
3. Renal Profile
4. Lipid Profile
5. Thyroid Function Panel
6. Electrolyte Panel
7. Specialty Chemical tests

End User

1. Hospitals
2. Diagnostic Laboratories
3. Research Laboratories & Institutes
4. Others

Region

1. North America

1.1 United States
1.2 Canada

2. Europe

2.1 Germany
2.2 United Kingdom
2.3 France
2.4 Italy
2.5 Netherlands
2.6 Spain

3. Asia Pacific

3.1 China
3.2 South Korea
3.3 Japan
3.4 India
3.5 Indonesia
3.6 Malaysia
3.7 Australia

4. Latin America

4.1 Argentina
4.2 Brazil
4.3 Mexico
4.4 Colombia

5. Middle East & Africa

5.1 Saudi Arabia
5.2 UAE
5.3 Israel
5.4 South Africa

6. Rest of World

Key Players

1. Thermo Fisher Scientific
2. Abbott Laboratories
3. Siemens Healthineers
4. Danaher Corporation
5. Johnson & Johnson
6. Sysmex ADR
7. HORIBA Ltd
8. Hitachi

Table of Contents

1. Introduction2. Research & Methodology3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Clinical Chemistry Analyzers Market
6. Market Share - Global Clinical Chemistry Analyzers Market
6.1 By Product Type
6.2 By Test Type
6.3 By End User
6.4 By Country
7. Product Type - Global Clinical Chemistry Analyzers Market
7.1 Analyzers
7.2 Reagents
7.3 Others
8. Test Type - Global Clinical Chemistry Analyzers Market
8.1 Basic Metabolic Panel
8.2 Liver Panel
8.3 Renal Profile
8.4 Lipid Profile
8.5 Thyroid Function Panel
8.6 Electrolyte Panel
8.7 Specialty Chemical tests
9. End User - Global Clinical Chemistry Analyzers Market
9.1 Hospitals
9.2 Diagnostics Laboratory
9.3 Research Laboratories & Institutes
9.4 Others
10. Countries - Global Clinical Chemistry Analyzers Market
10.1 North America
10.1.1 United States
10.1.2 Canada
10.2 Europe
10.2.1 Germany
10.2.2 United Kingdom
10.2.3 France
10.2.4 Italy
10.2.5 Netherlands
10.2.6 Spain
10.3 Asia Pacific
10.3.1 China
10.3.2 South Korea
10.3.3 Japan
10.3.4 India
10.3.5 Indonesia
10.3.6 Malaysia
10.3.7 Australia
10.4 Latin America
10.4.1 Argentina
10.4.2 Brazil
10.4.3 Mexico
10.4.4 Colombia
10.5 Middle East & Africa
10.5.1 Saudi Arabia
10.5.2 UAE
10.5.3 Israel
10.5.4 South Africa
10.6 Rest of World
11. Porter’s Five Forces Analysis - Global Clinical Chemistry Analyzers Market
11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes
12. SWOT Analysis - Global Clinical Chemistry Analyzers Market
12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat
13. Key Players
13.1 Thermo Fisher Scientific
13.1.1 Overview
13.1.2 Recent Development
13.1.3 Revenue
13.2 Abbott Laboratories
13.2.1 Overview
13.2.2 Recent Development
13.2.3 Revenue
13.3 Siemens Healthineers
13.3.1 Overview
13.3.2 Recent Development
13.3.3 Revenue
13.4 Danaher Corporation
13.4.1 Overview
13.4.2 Recent Development
13.4.3 Revenue
13.5 Johnson & Johnson
13.5.1 Overview
13.5.2 Recent Development
13.5.3 Revenue
13.6 Sysmex ADR
13.6.1 Overview
13.6.2 Recent Development
13.6.3 Revenue
13.7 HORIBA, Ltd.
13.7.1 Overview
13.7.2 Recent Development
13.7.3 Revenue
13.8 Hitachi
13.8.1 Overview
13.8.2 Recent Development
13.8.3 Revenue
List of Figures
Figure 01: Global - Clinical Chemistry Market (Billion US$), 2018 - 2023
Figure 02: Global - Forecast for Clinical Chemistry Market (Billion US$), 2024-2030
Figure 03: Product Type - Analyzers Market (Million US$), 2018 - 2023
Figure 04: Product Type - Forecast for Analyzers Market (Million US$), 2024-2030
Figure 05: Product Type - Reagents Market (Billion US$), 2018 - 2023
Figure 06: Product Type - Forecast for Reagents Market (Billion US$), 2024-2030
Figure 07: Product Type - Others Market (Billion US$), 2018 - 2023
Figure 08: Product Type - Forecast for Others Market (Billion US$), 2024-2030
Figure 09: Test Type - Basic Metabolic Panel Market (Million US$), 2018 - 2023
Figure 10: Test Type - Forecast for Basic Metabolic Panel Market (Million US$), 2024-2030
Figure 11: Test Type - Liver Panel Market (Million US$), 2018 - 2023
Figure 12: Test Type - Forecast for Liver Panel Market (Million US$), 2024-2030
Figure 13: Test Type - Renal Profile Market (Million US$), 2018 - 2023
Figure 14: Test Type - Forecast for Renal Profile Market (Million US$), 2024-2030
Figure 15: Test Type - Lipid Profile Market (Million US$), 2018 - 2023
Figure 16: Test Type - Forecast for Lipid Profile Market (Million US$), 2024-2030
Figure 17: Test Type - Thyroid Function Panel Market (Million US$), 2018 - 2023
Figure 18: Test Type - Forecast for Thyroid Function Panel Market (Million US$), 2024-2030
Figure 19: Test Type - Electrolyte Panel Market (Million US$), 2018 - 2023
Figure 20: Test Type - Forecast for Electrolyte Panel Market (Million US$), 2024-2030
Figure 21: Test Type - Specialty Chemical tests Market (Million US$), 2018 - 2023
Figure 22: Test Type - Forecast for Specialty Chemical tests Market (Million US$), 2024-2030
Figure 23: End User - Hospital Market (Million US$), 2018 - 2023
Figure 24: End User - Forecast for Hospital Market (Million US$), 2024-2030
Figure 25: End User - Diagnostics Laboratories Market (Million US$), 2018 - 2023
Figure 26: End User - Forecast for Diagnostics Laboratories Market (Million US$), 2024-2030
Figure 27: End User - Research Laboratories & Institutes Market (Million US$), 2018 - 2023
Figure 28: End User - Forecast for Research Laboratories & Institutes Market (Million US$), 2024-2030
Figure 29: End User - Others Market (Million US$), 2018 - 2023
Figure 30: End User - Forecast for Others Market (Million US$), 2024-2030
Figure 31: United States - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 32: United States - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 33: Canada - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 34: Canada - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 35: Germany - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 36: Germany - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 37: United Kingdom - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 38: United Kingdom - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 39: France - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 40: France - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 41: Italy - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 42: Italy - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 43: Netherlands - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 44: Netherlands - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 45: Spain - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 46: Spain - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 47: China - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 48: China - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 49: South Korea - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 50: South Korea - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 51: Japan - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 52: Japan - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 53: India - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 54: India - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 55: Indonesia - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 56: Indonesia - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 57: Malaysia - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 58: Malaysia - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 59: Australia - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 60: Australia - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 61: Argentina - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 62: Argentina - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 63: Brazil - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 64: Brazil - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 65: Mexico - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 66: Mexico - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 67: Colombia - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 68: Colombia - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 69: Saudi Arabia - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 70: Saudi Arabia - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 71: UAE - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 72: UAE - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 73: Israel - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 74: Israel - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 75: South Africa - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 76: South Africa - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 77: Rest of World - Clinical Chemistry Analyzers Market (Million US$), 2018 - 2023
Figure 78: Rest of World - Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024-2030
Figure 79: Thermo Fisher Scientific - Global Revenue (Billion US$), 2018 - 2023
Figure 80: Thermo Fisher Scientific - Forecast for Global Revenue (Billion US$), 2024-2030
Figure 81: Abbott Laboratories - Global Revenue (Billion US$), 2018 - 2023
Figure 82: Abbott Laboratories - Forecast for Global Revenue (Billion US$), 2024-2030
Figure 83: Siemens Healthineers - Global Revenue (Billion US$), 2018 - 2023
Figure 84: Siemens Healthineers - Forecast for Global Revenue (Billion US$), 2024-2030
Figure 85: Danaher Corporation - Global Revenue (Billion US$), 2018 - 2023
Figure 86: Danaher Corporation - Forecast for Global Revenue (Billion US$), 2024-2030
Figure 87: Johnson & Johnson - Global Revenue (Billion US$), 2018 - 2023
Figure 88: Johnson & Johnson - Forecast for Global Revenue (Billion US$), 2024-2030
Figure 89: Sysmex ADR - Global Revenue (Million US$), 2018 - 2023
Figure 90: Sysmex ADR - Forecast for Global Revenue (Million US$), 2024-2030
Figure 91: HORIBA, Ltd. - Global Revenue (Million US$), 2018 - 2023
Figure 92: HORIBA, Ltd. - Forecast for Global Revenue (Million US$), 2024-2030
Figure 93: Hitachi - Global Revenue (Billion US$), 2018 - 2023
Figure 94: Hitachi - Forecast for Global Revenue (Billion US$), 2024-2030
List of Tables
Table 01: Global - Clinical Chemistry Market Share by Product Type (Percent), 2018 - 2023
Table 02: Global - Forecast for Clinical Chemistry Market Share by Product Type (Percent), 2024-2030
Table 03: Global - Clinical Chemistry Market Share by Test Type (Percent), 2018 - 2023
Table 04: Global - Forecast for Clinical Chemistry Market Share by Test Type (Percent), 2024-2030
Table 05: Global - Clinical Chemistry Market Share by End Users (Percent), 2018 - 2023
Table 06: Global - Forecast for Clinical Chemistry Market Share by End Users (Percent), 2024-2030
Table 07: Global - Clinical Chemistry Market Share by Regions (Percent), 2018 - 2023
Table 08: Global - Forecast for Clinical Chemistry Market Share by Regions (Percent), 2024-2030

Companies Mentioned

  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Siemens Healthineers
  • Danaher Corporation
  • Johnson & Johnson
  • Sysmex ADR
  • HORIBA Ltd
  • Hitachi

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Table Information